SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049154
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:36
Documents
8
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_pyxs-14a.htm DEF 14A 728443
2 GRAPHIC img107367540_0.jpg GRAPHIC 29935
3 GRAPHIC img107367540_1.jpg GRAPHIC 17889
4 GRAPHIC img107367540_2.jpg GRAPHIC 41024
5 GRAPHIC img107367540_3.jpg GRAPHIC 65589
6 GRAPHIC img107367540_4.jpg GRAPHIC 17889
7 GRAPHIC img107367540_5.jpg GRAPHIC 1708129
8 GRAPHIC img107367540_6.jpg GRAPHIC 228870
  Complete submission text file 0000950170-24-049154.txt   3632813
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40881 | Film No.: 24883973
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)